Biohaven Ltd: Administer Novel Trop-2 Targeted Antibody Drug Conjugate (ADC) Bhv-1510 for the First Patient with Advanced or Metastatic Epithelial Tumors
Biohaven Ltd：为晚期或转移性上皮肿瘤的首位患者服用新型 Trop-2 定向抗体药物偶联物 (ADC) Bhv-1510
Biohaven Ltd: Administer Novel Trop-2 Targeted Antibody Drug Conjugate (ADC) Bhv-1510 for the First Patient with Advanced or Metastatic Epithelial Tumors
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.